Approval of alteplase in Europe: Will it change stroke management?

Lancet Neurology

Volumn 2, Issue 4, 2003, Pages 207-208

  Kaste, Markku ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; AGE DISTRIBUTION; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CLINICAL TRIAL; CONFIDENCE INTERVAL; DEATH; DRUG APPROVAL; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; EUROPE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE; HOSPITAL ADMISSION; HUMAN; MEDICAL PRACTICE; META ANALYSIS; MORTALITY; ONSET AGE; OPEN STUDY; PARENCHYMA; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; RISK ASSESSMENT; SCALE UP; SCORING SYSTEM; SHORT SURVEY; STATISTICAL SIGNIFICANCE; STROKE; TREATMENT INDICATION; TREATMENT OUTCOME; ARTICLE; CLINICAL PRACTICE;

CEREBROVASCULAR ACCIDENT; DRUG APPROVAL; EUROPE; FIBRINOLYTIC AGENTS; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0042469014     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(03)00343-0     Document Type: Letter

References (14)

1. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 343:1994;311-322.
2. Wardlaw JM, del Zoppo GJ, Yamaguchi T. Thrombolysis in acute ischaemic stroke. Cochrane Database Syst Rev 2000(2):CD000213.
3. Lenzer J. Alteplase for stroke: money and optimistic claims buttress the "brain attack" campaign. BMJ. 324:2002;723-729.
4. Graham G.D. Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data. Ann Neurol. 52:(suppl 1):2002;S24.
5. Kaste M, for the ATLANTIS, ECASS, and NINDS rt-PA Study Group Investigators. Is there benefit after 3 hours: a pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Proceedings of the 7th International Symposium on Thrombolysis and Acute Stroke Therapy, Lyon, 2002.
6. Sudlow C.L.M., Warlow C.P. Comparable studies of the incidence of stroke and its pathological subtypes: results from an international collaboration. Stroke. 28:1997;491-499.
7. Halm E.A., Lee C., Chassin M.R. Is volume related to outcome in health care: a systematic review and methodologic critique of the literature. Ann Intern Med. 137:2002;511-520.
8. Nathens A.B., Jurkovich G.J., Cummings P., et al. The effect of organized systems of trauma care on motor vehicle crash mortality. JAMA. 283:2000;1990-1994.
9. Alberts M.J., Hademenos G., Latchaw R.E., et al. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA. 283:2000;3102-3109.
10. Harraf F., Sharma A.K., Brown M.M., et al. A multicentre observational study of presentation and early assessment of acute stroke. BMJ. 325:2002;17-20.
11. Lindsberg P.J., Kaste M. Thrombolysis for acute stroke. Curr Opin Neurol. 16:2003;73-80.
12. Kaste M., Thomassen L., Grond M., et al. Thrombolysis for acute ischemic stroke: a consensus statement of the 3rd Karolinska Stroke Update, October 30-31, 2000. Stroke. 32:2001;2717-2718.
13. Lindsberg PJ, Soinne L, Roine RO, et al. Community-based thrombolytic therapy of acute ischemic stroke in Helsinki. Stroke (in press).
14. Boersma E., Maas A.C.P., Deckers J.W., Simoons M.L. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet. 348:1996;771-775.